Related Experiment Video
Updated: Jun 19, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Subitem-level multi-scale assessment and machine learning for three-class cognitive status classification in
Ying-Che Chen1, Rwei-Ling Yu2,3,4,5, Sun-Yuan Hsieh6,7,8,9,10,11
1The Institute of Medical Informatics, National Cheng Kung University, Tainan, Taiwan (R.O.C.).
This study developed an explainable machine learning model to accurately classify cognitive states in Parkinson's disease (PD). The model effectively identifies individuals with mild cognitive impairment (PD-MCI) and dementia (PDD), aiding early clinical intervention.
Area of Science:
- Neurology
- Artificial Intelligence
- Biomedical Informatics
Background:
- Cognitive impairment is common in Parkinson's disease (PD), necessitating accurate early classification for effective intervention.
- Distinguishing between normal cognition (PD-NC), mild cognitive impairment (PD-MCI), and dementia (PDD) is crucial for patient management.
Purpose of the Study:
- To develop and validate a machine learning framework for classifying cognitive states in Parkinson's disease patients.
- To enhance model interpretability using SHapley Additive exPlanations (SHAP) for clinical relevance.
Main Methods:
- Utilized data from the Parkinson's Progression Markers Initiative (PPMI) cohort.
- Developed a two-stage ensemble model (XGBoost and MLP) with SMOTE-Tomek for class imbalance.
- Employed strict hold-out validation and SHAP for feature importance analysis.
Main Results:
- Achieved strong and balanced classification performance across all three cognitive subgroups (PD-NC, PD-MCI, PDD).
- Demonstrated high accuracy in identifying cognitively impaired individuals, with an AUC exceeding 0.85 for three-class discrimination.
- SHAP analysis confirmed the clinical significance of predictors like MoCA scores and activities of daily living assessments.
Conclusions:
- The proposed explainable two-stage model offers robust cognitive stratification for Parkinson's disease patients.
- The model shows potential as a scalable tool for early dementia risk identification and clinical decision support in neurology.
- External validation on diverse cohorts is recommended prior to widespread clinical implementation.
More Related Videos
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019